Atopic dermatitis, commonly known as eczema, is a chronic inflammatory skin condition affecting millions of individuals worldwide. In North America, this dermatological challenge presents a significant healthcare burden, prompting a deeper examination of the market dynamics surrounding its diagnosis, treatment, and.